Karachi, Highnoon Laboratories Limited informed Pakistan Stock Exchange about the recommendations made by the board of directors in the meeting held at Lahore on March 16, 2022.
The agenda of the meeting was discussion of Unconsolidated and consolidated profit and loss account for Year ended December 31, 2021 which portrayed a profit of Rs. 1,808,033,162 and Rs. 1,856,421,942 with earnings per share 47.48 and 48.76 basic and diluted respectively.
Further, 200% payment of cash dividend, bonus shares and right shares was agreed.
Furthermore, the share transfer books of the company will remain closed from April 11, 2022 to April 18, 2022 (both days inclusive).
Highnoon Laboratories Limited was incorporated in Pakistan. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and allied consumer products.
The total numbers of shares are 38,076,441. The Earnings per share is 41.01 in 2020 which was 28.05 in 2019. The Profit after Taxation is 1,420,736,000 in 2020 which was 971,013,000 in 2019.